Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Execs Urge Post-Brexit Regulatory Deal, As EMA Focuses On Redistribution Of MHRA Work

Jul 07 2017

• By Ian Schofield

Brexit — Industry is piling on the pressure for a post-Brexit regulatory alignment deal.

Related Content

Lobbying Pays Off As UK Ministers Speak Out On Post-Brexit Regulatory Collaboration

Jul 05 2017

EU Postpones Decision On EMA’s New Home To November

Jun 23 2017

EMA’s Multinational Approach Brings All But Two Member States Into New Drug Assessor Fold

Feb 07 2017

Additional Topics

Europe United Kingdom Brexit Business Strategies Companies Regulation BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.